Premium
An adenoviral system for tetracycline‐regulated TGF‐β expression mediates a reversible cell cycle arrest
Author(s) -
Wettergreen Matthew A.,
Hunniford John W.,
Crawford John M.,
Adami Guy R.
Publication year - 2001
Publication title -
european journal of oral sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.802
H-Index - 93
eISSN - 1600-0722
pISSN - 0909-8836
DOI - 10.1034/j.1600-0722.2001.00105.x
Subject(s) - biology , cell growth , viral vector , recombinant dna , cell culture , microbiology and biotechnology , cancer research , cell cycle , cell , immunology , gene , genetics
The ability to regulate the proliferation of normal cells in a reversible manner would be a useful adjunct to some clinical therapies, including many types of cancer chemotherapy and surgery for periodontal regeneration. While the application of recombinant growth factors and cytokines to target cells is a logical approach to regulate cell proliferation, the high turnover rates of these peptide factors often make this approach impractical. Recombinant adenoviral vectors can be used to direct the expression of transgene products such as growth factors in many cell types in vitro and in vivo . We have adapted the tetracycline‐regulated expression system to allow regulated transforming growth factor (TGF)‐β1 expression using recombinant adenovirus. We demonstrate that infection with a recombinant TGF‐β‐encoding virus system in primary human oral keratinocytes and in a lung epithelial cell line is sufficient to allow a cell cycle arrest that is reversible upon tetracycline addition. This inhibition is efficient even after the infection of a minority of cells in a population. These results highlight the possibility of using low level infection with recombinant adenovirus to cause short‐term blocks on cell proliferation.